NTRR Partner S2O2 Expands Into Denver Market to Capitalize on Cannabis Boom

TAMPA, Fla.--(BUSINESS WIRE)--

As Neutra Corp. NTRR prepares to ramp up business activities in Colorado's booming cannabis industry, the company announced today that its joint venture partner Surface to Air Solutions (S2O2) opened a new branch office in Denver to spearhead operations there.

The Denver office's first order of business will be to finalize a new product-testing deal that will allow NTRR and S2O2 to demonstrate the efficacy of their non-toxic, antimicrobial coatings in the germ- and pest-free cultivation of medical-grade cannabis.

"Our joint venture is on the cusp of signing an agreement with the top names in Colorado cannabis cultivation," said NTRR CEO Chris Brown. "Colorado is on the cutting edge of the global cannabis movement and marketplace, and this new office and position will allow NTRR to pursue the business we need to compete in this rapidly rising industry."

NTRR has been seeking out new partners in the Centennial State to help test and improve the antimicrobial products created by S202 to eliminate germs and odors from cannabis farming, refining and retail businesses. When applied to surfaces, S2O2's environmentally friendly formulas form an invisible, long-lasting coating that actively protects surfaces from the build-up of organic matter—including bacteria, molds, germs and allergens—without the use of harsh chemicals.

Additionally, the Colorado farmers will also test two other S2O2 products in their facilities: Nano Gro—a colloidal emulsion that accelerates plants' photosynthesis process, increases their production of sugar and protects them against bacteria, pests and mildew—as well as a hydroxyl generator to improve air quality.

NTRR believes it can provide ideal solutions to growers that are wary of using pesticides and other harsh chemicals on or near their crops. S2O2's suite of products is already being tested in California and Canada.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals GWPRF, INSYS Therapeutics, Inc. INSY and ENDEXX Corp. EDXC, delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.